1. Home
  2. EIG vs EVO Comparison

EIG vs EVO Comparison

Compare EIG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$48.94

Market Cap

911.6M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.92

Market Cap

778.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
EVO
Founded
2000
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
911.6M
778.3M
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
EIG
EVO
Price
$48.94
$1.92
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
143.4K
40.5K
Earning Date
04-29-2026
04-08-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$1.26
$10.05
P/E Ratio
$23.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$1.87
52 Week High
$52.59
$4.27

Technical Indicators

Market Signals
Indicator
EIG
EVO
Relative Strength Index (RSI) 50.83 41.02
Support Level $48.30 $1.90
Resistance Level $52.32 $2.20
Average True Range (ATR) 0.97 0.04
MACD 0.04 0.01
Stochastic Oscillator 76.20 15.15

Price Performance

Historical Comparison
EIG
EVO

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: